Dolby Laboratories (DLB) Liabilities and Shareholders Equity (2016 - 2025)
Dolby Laboratories' Liabilities and Shareholders Equity history spans 17 years, with the latest figure at $3.2 billion for Q4 2025.
- For Q4 2025, Liabilities and Shareholders Equity rose 1.06% year-over-year to $3.2 billion; the TTM value through Dec 2025 reached $12.8 billion, up 4.54%, while the annual FY2025 figure was $3.2 billion, 3.79% up from the prior year.
- Liabilities and Shareholders Equity reached $3.2 billion in Q4 2025 per DLB's latest filing, down from $3.2 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.2 billion in Q1 2025 to a low of $2.7 billion in Q3 2022.
- Average Liabilities and Shareholders Equity over 5 years is $3.0 billion, with a median of $3.1 billion recorded in 2021.
- Peak YoY movement for Liabilities and Shareholders Equity: fell 13.4% in 2022, then grew 10.79% in 2023.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $3.1 billion in 2021, then dropped by 11.48% to $2.7 billion in 2022, then rose by 6.8% to $2.9 billion in 2023, then grew by 7.6% to $3.2 billion in 2024, then grew by 1.06% to $3.2 billion in 2025.
- Per Business Quant, the three most recent readings for DLB's Liabilities and Shareholders Equity are $3.2 billion (Q4 2025), $3.2 billion (Q3 2025), and $3.2 billion (Q2 2025).